Mostrar el registro sencillo del ítem

dc.contributor.author
Martínez, Helberth Llantén  
dc.contributor.author
Riafrecha, Leonardo Ezequiel  
dc.contributor.author
Colinas, Pedro Alfonso  
dc.date.available
2021-03-10T03:10:32Z  
dc.date.issued
2019-07  
dc.identifier.citation
Martínez, Helberth Llantén; Riafrecha, Leonardo Ezequiel; Colinas, Pedro Alfonso; C-cinnamoyl glycosides: An emerging “Tail” for the development of selective carbonic anhydrase inhibitors; Bentham Science Publishers; Current Medicinal Chemistry; 26; 15; 7-2019; 2601-2608  
dc.identifier.issn
0929-8673  
dc.identifier.uri
http://hdl.handle.net/11336/127883  
dc.description.abstract
Attachment of different tails to the well-known carbonic anhydrase (CA) pharma-cophores has led to the development of several new CA inhibitors (CAIs). A very good example of such “tails” is constituted by carbohydrates, which represent a wide range of chemo-types, leading thus to a high number of new CAIs. In the last years, several C-cinnamoyl glycosides containing different scaffolds have been prepared and investigated as carbonic anhydrase inhibitors, showing that some of them are very potent and selective CAIs. This article will review the latest developments in the synthesis and biological activity of these C-glycosides.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Bentham Science Publishers  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ANTITUMORAL  
dc.subject
CAIS  
dc.subject
CARBOHYDRATE  
dc.subject
CARBONIC ANHYDRASE  
dc.subject
ENZYME INHIBITION  
dc.subject
HETEROCYCLE  
dc.subject
TUBERCULOSIS  
dc.subject.classification
Química Orgánica  
dc.subject.classification
Ciencias Químicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
C-cinnamoyl glycosides: An emerging “Tail” for the development of selective carbonic anhydrase inhibitors  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2021-03-05T18:36:01Z  
dc.journal.volume
26  
dc.journal.number
15  
dc.journal.pagination
2601-2608  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Oak Park  
dc.description.fil
Fil: Martínez, Helberth Llantén. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Laboratorio de Estudio de Compuestos Orgánicos; Argentina  
dc.description.fil
Fil: Riafrecha, Leonardo Ezequiel. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Laboratorio de Estudio de Compuestos Orgánicos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina  
dc.description.fil
Fil: Colinas, Pedro Alfonso. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Laboratorio de Estudio de Compuestos Orgánicos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina  
dc.journal.title
Current Medicinal Chemistry  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2174/0929867325666180713122907  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.eurekaselect.com/163757/article